Bolt Biotherapeutics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1286045,
    "name": "Bolt Biotherapeutics, Inc.",
    "stock_name": "Bolt Biotherapeutics, Inc.",
    "full_name": "Bolt Biotherapeutics, Inc.",
    "name_url": "stocks-analysis/bolt-biotherapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "5.42",
    "chg": 0.11,
    "chgp": "2.07%",
    "dir": 1,
    "prev_price": "5.31",
    "mcapval": "9.89",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US0977021049",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "11.71 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bolt-biotherapeutics-inc-1286045-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Bolt Biotherapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bolt-biotherapeutics-inc-technically-bullish-or-bearish-3547509",
        "imagepath": "",
        "date": "2025-09-20 19:57:07",
        "description": "As of 2 September 2025, the technical trend for Bolt Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI indicates a bullish monthly signal but no signal on the weekly. However, the moving averages are bearish on the daily, and Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames. Additionally, the KST is mildly bullish weekly but bearish monthly, and the OBV is mildly bearish weekly with no trend monthly. \n\nIn terms of performance, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -50.57% versus the S&P 500's 12.22%, and a one-year return of -57.46% compared to the S&P 500's 17.14%...."
      },
      {
        "title": "Is Bolt Biotherapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bolt-biotherapeutics-inc-overvalued-or-undervalued-3543857",
        "imagepath": "",
        "date": "2025-09-20 18:30:45",
        "description": "As of 30 March 2022, the valuation grade for Bolt Biotherapeutics, Inc. moved from does not qualify to risky, indicating increased scrutiny regarding its financial health. The company appears to be overvalued, particularly given its negative performance metrics. Key ratios such as the Price to Book Value at 0.26, EV to EBIT at 0.39, and EV to EBITDA at 0.40 highlight significant concerns about its valuation relative to its financial performance.\n\nIn comparison to its peers, Bolt Biotherapeutics has a P/E ratio of -0.1998, while Assembly Biosciences, Inc. and Fortress Biotech, Inc. show even more negative valuations at -9.3127 and -1.1589, respectively. This suggests that while Bolt is not alone in its struggles, it still faces substantial challenges. Over the past year, Bolt Biotherapeutics has underperformed significantly, with a return of -57.46% compared to the S&P 500's gain of 17.14%, reinforcing the n..."
      }
    ],
    "total": 6,
    "sid": "1286045",
    "stock_news_url": "https://www.marketsmojo.com/news/bolt-biotherapeutics-inc-1286045"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Bolt Biotherapeutics, Inc. technically bullish or bearish?

2025-09-20 19:57:07

As of 2 September 2025, the technical trend for Bolt Biotherapeutics, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators showing mixed signals. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI indicates a bullish monthly signal but no signal on the weekly. However, the moving averages are bearish on the daily, and Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames. Additionally, the KST is mildly bullish weekly but bearish monthly, and the OBV is mildly bearish weekly with no trend monthly. In terms of performance, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -50.57% versus the S&P 500's 12.22%, and a one-year return of -57.46% compared to the S&P 500's 17.14%....

Is Bolt Biotherapeutics, Inc. overvalued or undervalued?

2025-09-20 18:30:45

As of 30 March 2022, the valuation grade for Bolt Biotherapeutics, Inc. moved from does not qualify to risky, indicating increased scrutiny regarding its financial health. The company appears to be overvalued, particularly given its negative performance metrics. Key ratios such as the Price to Book Value at 0.26, EV to EBIT at 0.39, and EV to EBITDA at 0.40 highlight significant concerns about its valuation relative to its financial performance. In comparison to its peers, Bolt Biotherapeutics has a P/E ratio of -0.1998, while Assembly Biosciences, Inc. and Fortress Biotech, Inc. show even more negative valuations at -9.3127 and -1.1589, respectively. This suggests that while Bolt is not alone in its struggles, it still faces substantial challenges. Over the past year, Bolt Biotherapeutics has underperformed significantly, with a return of -57.46% compared to the S&P 500's gain of 17.14%, reinforcing the n...

View All News